Centre de Connaissances

Ajouter une ressource

1383 correspondances trouvées

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm - update 15 March 2022

Vaccins et dispositifs d'administration Chine COVID-19

Immunization dashboard

Données

Management and Facilitation of a Country COVID-19 Intra-Action Review (IAR)

Gestion de programme COVID-19

Guidance for conducting a country COVID-19 intra-action review (IAR)

Gestion de programme COVID-19

Technical Resources for Improving Immunization Coverage and Equity

Gestion de programme

ACT now, ACT together 2020-2021 Impact Report

Initiatives mondiales COVID-19

Inequality monitoring in immunization: a step-by-step manual

Données

KN2 The Lessons of COVID-19 for Vaccine Development

Initiatives mondiales COVID-19

Supportive supervision for COVID-19 vaccination

Gestion de programme COVID-19

Reporting form for AEFI

Prestation de services COVID-19

COVID-19 Vaccine Explainer - COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) - UPDATED JULY 2022

Vaccins et dispositifs d'administration COVID-19

Identifying Interventions to Reduce MOV: Health Worker Issues

Prestation de services

Contributions of the polio network to the COVID-19 response: turning the challenge into an opportunity for polio transition

Gestion de programme Polio COVID-19

Mini-cPIE, aka COVID-19 Vaccination Intra-action Review (IAR)

Gestion de programme COVID-19

Sample size calculator for evaluation of COVID-19 vaccine effectiveness

Vaccins et dispositifs d'administration COVID-19

Evaluation of COVID-19 vaccine effectiveness

Vaccins et dispositifs d'administration COVID-19

Data for action: achieving high uptake of COVID-19 vaccines: Interim Guidance

Gestion de programme COVID-19

Conducting community engagement for COVID-19 vaccines: Interim guidance

Gestion de programme COVID-19

Acceptance and demand for COVID-19 vaccines: Interim guidance

Gestion de programme COVID-19

Considerations for optimizing deployment of ChAdOx1-S [recombinant] vaccines in a time-limited constrained supply situation (AstraZeneca/AZD1222-Vaxzevria, AstraZeneca/SK Bioscience and SII/Covishield vaccines)

Gestion de programme Tchad COVID-19

Filtres